Jefferies Downgrades VistaGen Therapeutics (VTGN) to Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

July 22, 2022 11:12 AM EDT
Get Alerts VTGN Hot Sheet
Price: $0.27 --0%

Rating Summary:
    2 Buy, 7 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE

Jefferies analyst Andrew Tsai downgraded VistaGen Therapeutics (NASDAQ: VTGN) from Buy to Hold with a price target of $0.20 (from $8.00).


For an analyst ratings summary and ratings history on VistaGen Therapeutics click here. For more ratings news on VistaGen Therapeutics click here.


Shares of VistaGen Therapeutics closed at $1.07 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades